Cargando…
Salvianolic Acid B in Microemulsion Formulation Provided Sufficient Hydration for Dry Skin and Ameliorated the Severity of Imiquimod-induced Psoriasis-like Dermatitis in Mice
Psoriasis is a chronic inflammatory skin disorder with a pathogenesis involving the interleukin-23/interleukin-17 axis. Salvianolic acid B exerts several pharmacological effects, such as antioxidation, anti-inflammation, and antitumor effects. The anti-psoriatic effects of salvianolic acid B have no...
Autores principales: | Guo, Jiun-Wen, Cheng, Yu-Pin, Liu, Chih-Yi, Thong, Haw-Yueh, Huang, Chi-Jung, Lo, Yang, Wu, Chen-Yu, Jee, Shiou-Hwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284938/ https://www.ncbi.nlm.nih.gov/pubmed/32429542 http://dx.doi.org/10.3390/pharmaceutics12050457 |
Ejemplares similares
-
Magnolol may contribute to barrier function improvement on imiquimod-induced psoriasis-like dermatitis animal model via the downregulation of interleukin-23
por: Guo, Jiun-Wen, et al.
Publicado: (2021) -
Phospholipid-Based Microemulsions for Cutaneous Imiquimod Delivery
por: Panoutsopoulou, Eleni, et al.
Publicado: (2022) -
Amelioration of imiquimod-induced psoriasis-like dermatitis in mice by DSW therapy inspired hydrogel
por: He, Xiang, et al.
Publicado: (2020) -
Brevilin A Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis and Reduces Th17 Differentiation in Psoriasis Patients
por: Yen, Ling-Jung, et al.
Publicado: (2022) -
IDO-expressing Fibroblasts Suppress the Development of Imiquimod-induced Psoriasis-like Dermatitis
por: Elizei, Sanam Salimi, et al.
Publicado: (2018)